Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
Ontology highlight
ABSTRACT: Duchenne muscular dystrophy (DMD) causes progressive disability in 1 of every 5,000 boys due to the lack of functional dystrophin protein. Despite much advancement in knowledge about DMD disease presentation and progression-attributable in part to studies using mouse and canine models of the disease-current DMD treatments are not equally effective in all patients. There remains, therefore, a need for translational animal models in which novel treatment targets can be identified and evaluated. Golden Retriever muscular dystrophy (GRMD) is a phenotypically and genetically homologous animal model of DMD. As with DMD, speed of disease progression in GRMD varies substantially. However, unlike DMD, all GRMD dogs possess the same causal mutation; therefore genetic modifiers of phenotypic variatio
SUBMITTER: Brinkmeyer-Langford C
PROVIDER: S-EPMC5858769 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA